Scandion Oncology Dividend
Dividend criteria checks 0/6
Scandion Oncology does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -kr0.96 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
We Think Scandion Oncology (STO:SCOL) Needs To Drive Business Growth Carefully
Aug 02
Companies Like Scandion Oncology (STO:SCOL) Are In A Position To Invest In Growth
Feb 01Here's Why We're Not Too Worried About Scandion Oncology's (STO:SCOL) Cash Burn Situation
May 26We're Hopeful That Scandion Oncology (NGM:SCOL) Will Use Its Cash Wisely
Jan 06
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SCOL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SCOL's dividend payments have been increasing.
Dividend Yield vs Market
| Scandion Oncology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SCOL) | n/a |
| Market Bottom 25% (SE) | 1.5% |
| Market Top 25% (SE) | 4.3% |
| Industry Average (Biotechs) | 1.8% |
| Analyst forecast in 3 Years (SCOL) | n/a |
Notable Dividend: Unable to evaluate SCOL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SCOL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SCOL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SCOL has not reported any payouts.